Mild Neurocognitive Disorder: Conceptual Issues, Neuropsychological Assessment, and Intervention: WS406

This intermediate workshop helps clinicians and researchers understand the detection, clinical significance, and current evidence-based treatment for individuals with mild neurocognitive disorders (mNCD). Topics include a review of normal versus pathological aging, the relationship between depression and cognitive impairment, and neuropsychological assessment of mNCD (including teleneuropsychology). In the absence of biomarkers, neuropsychological assessment remains a critical lens in understanding fundamental aspects of aging in order to diagnose, treat, and investigate age-related cognitive changes effectively. Interventions aimed at promoting healthy brain and cognitive aging are also discussed.

Webinars are converted to video on-demand programs with closed captioning after the live air date

• Describe three challenges in diagnosing mNCD, including how depression relates to mNCD.
• Provide three ways in which neuropsychological assessments are essential in diagnosing mNCD in older adults.
• Explain the usefulness of teleneuropsychological evaluations during the COVID-19 pandemic and the likelihood of long-term changes in assessment practices.
• Provide three evidence-based interventions to maintain cognitive health and prolong function for older adults.

Lydia Y. Cho, PhD, and Regan E. Patrick, PhD